Biotech · Private company

PharmaMar

Track this companyFree. Adds PharmaMar to your Dealase workspace and tells you when its record changes.

Clinical trials244 recruiting or active

Pipeline programs38From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline38

Cyclophosphamide (CTX)Phase 3 · Small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
DexamethasonePhase 3 · Relapsed/Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
DoxorubicinPhase 3 · LeiomyosarcomaClinicalTrials.gov · fetched Nov 12, 2026
Doxorubicin (DOX)Phase 3 · Small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
IrinotecanPhase 3 · Relapsed Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
LurbinectedinPhase 3 · LeiomyosarcomaClinicalTrials.gov · fetched Nov 12, 2026
LurbinectedinPhase 3 · Relapsed Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Lurbinectedin (PM01183)Phase 3 · Small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Lurbinectedin (PM01183)Phase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
Pegylated liposomal doxorubicin (PLD)Phase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
PlitidepsinPhase 3 · Relapsed/Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
TopotecanPhase 3 · Small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
TopotecanPhase 3 · Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
TopotecanPhase 3 · Relapsed Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Vincristine (VCR)Phase 3 · Small-cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Aplidin (plitidepsin)Phase 2 · Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
APLIDIN (plitidepsin)Phase 2 · MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026
DocetaxelPhase 2 · Non-Small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
DoxorubicinPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
GemcitabinePhase 2 · Non-Small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
IrinotecanPhase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
IrinotecanPhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
LurbinectedinPhase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
lurbinectedin (PM01183)Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
lurbinectedin (PM01183)Phase 2 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Lurbinectedin (PM01183)Phase 2 · Non-Small Cell Lung Cancer (NSCLC)ClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 2 · Advanced MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
plitidepsinPhase 2 · LymphomaClinicalTrials.gov · fetched Nov 12, 2026
PM01183Phase 2 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
PM060184Phase 2 · Advanced Colorectal CancerClinicalTrials.gov · fetched Nov 12, 2026
PM54Phase 2 · Advanced MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
PM54Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
ZalypsisPhase 2 · Ewing's SarcomaClinicalTrials.gov · fetched Nov 12, 2026
Zalypsis ( PM00104)Phase 2 · Uterine Cervical CancerClinicalTrials.gov · fetched Nov 12, 2026
Gemcitabine plus PM060184Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PM00104Phase 1 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
PM01183 + paclitaxel +/- bevacizumabPhase 1 · Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
PM14Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials24

Study of PM54 in Combination With Cytotoxic and Targeted Agents in Adult Participants With Advanced MalignanciesPHASE1_PHASE2 · NOT_YET_RECRUITING · started Nov 12, 2026ClinicalTrials.gov NCT07839819 · fetched Nov 12, 2026
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced MalignanciesPHASE1_PHASE2 · RECRUITING · started May 21, 2026ClinicalTrials.gov NCT07644039 · fetched Nov 12, 2026
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)PHASE3 · ACTIVE_NOT_RECRUITING · started Sep 21, 2023ClinicalTrials.gov NCT06088290 · fetched Nov 12, 2026
Clinical Trial of PM54 in Advanced Solid Tumors Patients.PHASE1 · RECRUITING · started Apr 28, 2023ClinicalTrials.gov NCT05841563 · fetched Nov 12, 2026
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)PHASE3 · COMPLETED · started Jul 22, 2022ClinicalTrials.gov NCT05153239 · fetched Nov 12, 2026
Clinical Trial of PM60184 in Advanced Colorectal Cancer After Standard TreatmentPHASE2 · COMPLETED · started Jan 16, 2018ClinicalTrials.gov NCT03427268 · fetched Nov 12, 2026
PM14 Administered Intravenously to Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Sep 6, 2017ClinicalTrials.gov NCT05076396 · fetched Nov 12, 2026
A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell LymphomaPHASE2 · TERMINATED · started Oct 25, 2016ClinicalTrials.gov NCT03070964 · fetched Nov 12, 2026
Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung CancerPHASE3 · COMPLETED · started Aug 30, 2016ClinicalTrials.gov NCT02566993 · fetched Nov 12, 2026
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsPHASE1_PHASE2 · COMPLETED · started May 6, 2016ClinicalTrials.gov NCT02611024 · fetched Nov 12, 2026
Clinical Trial of Lurbinectedin (PM01183) in Selected Advanced Solid TumorsPHASE2 · COMPLETED · started Aug 25, 2015ClinicalTrials.gov NCT02454972 · fetched Nov 12, 2026
Evaluation of the Effect of Lurbinectedin (PM01183) on Cardiac Repolarization in Patients With Selected Solid TumorsPHASE2 · COMPLETED · started Aug 12, 2015ClinicalTrials.gov NCT02451007 · fetched Nov 12, 2026
Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer PatientsPHASE3 · COMPLETED · started May 1, 2015ClinicalTrials.gov NCT02421588 · fetched Nov 12, 2026
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Dec 12, 2014ClinicalTrials.gov NCT02533674 · fetched Nov 12, 2026
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube CancerPHASE3 · COMPLETED · started Oct 16, 2013ClinicalTrials.gov NCT01846611 · fetched Nov 12, 2026
A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) PatientsPHASE2 · COMPLETED · started Sep 11, 2013ClinicalTrials.gov NCT01951157 · fetched Nov 12, 2026
Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid TumorsPHASE1 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01831089 · fetched Nov 12, 2026
A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast CancerPHASE2 · COMPLETED · started Jun 13, 2012ClinicalTrials.gov NCT01525589 · fetched Nov 12, 2026
Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of ChemotherapyPHASE2 · COMPLETED · started Dec 1, 2010ClinicalTrials.gov NCT01222767 · fetched Nov 12, 2026
Clinical Trial of Aplidin® in Patients With Primary MyelofibrosisPHASE2 · COMPLETED · started Jul 1, 2010ClinicalTrials.gov NCT01149681 · fetched Nov 12, 2026
Aplidin - Dexamethasone in Relapsed/Refractory MyelomaPHASE3 · COMPLETED · started Jun 1, 2010ClinicalTrials.gov NCT01102426 · fetched Nov 12, 2026
Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic ChemotherapyPHASE2 · TERMINATED · started Aug 1, 2009ClinicalTrials.gov NCT00900562 · fetched Nov 12, 2026
A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or LymphomaPHASE1 · TERMINATED · started May 1, 2006ClinicalTrials.gov NCT00359294 · fetched Nov 12, 2026
A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate CancerPHASE2 · TERMINATED · started Feb 1, 2005ClinicalTrials.gov NCT00780975 · fetched Nov 12, 2026